Mistry et al. (2015) [16] in an array of comparative genomic hybridization analysis of 886 pediatric gliomas alsodefined that CDKN2A deletions had a central role in low-grade glioma malignant transformation. This evidence concerns the gene CDKN2A and central nervous system cancer.